New Key Statistics Module, Z-Score and F-Score
IST:ORZAX Key Ratios
| Market Cap ₺ M | 26,862.50 |
| Enterprise Value ₺ M | 30,239.47 |
| P/E(ttm) | 25.53 |
| PE Ratio without NRI | 26.38 |
| Forward PE Ratio | -- |
| Price/Book | 6.95 |
| Price/Sales | 3.66 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) ₺ M | 7,331.00 |
| EPS (TTM) ₺ | 3.43 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 45.60 |
| EV-to-EBIT | 12.15 |
| EV-to-EBITDA | 12.01 |
| PEG | -- |
| Shares Outstanding M | 307.00 |
| Net Margin (%) | 14.36 |
| Operating Margin % | 34.24 |
| Pre-tax Margin (%) | 21.26 |
| Quick Ratio | 1.48 |
| Current Ratio | 1.80 |
| ROA % (ttm) | 14.68 |
| ROE % (ttm) | 31.53 |
| ROIC % (ttm) | 29.29 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
IST:ORZAX Number of Guru Trades
IST:ORZAX Volume of Guru Trades
Gurus Latest Trades with IST:ORZAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
IST:ORZAX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers